A study to investigate the effect of single dose of AZD6094 (600 mg) on cardiac repolarization in healthy volunteers

Trial Identifier:	D5084C00001
Sponsor:	AstraZeneca
Collaborator:	PAREXEL
NCTID::	NCT03258515
Start Date:	September 2017
Primary Completion Date:	March 2018
Study Completion Date:	March 2018
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.